← Evidence map

ReviewLa Revue de medecine interne2021

[COVID-19: Still a place for tocilizumab?]

Q Richier et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

2 papers cite it

2021
2022
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 33288230